Epinephrine inhalation - Alkermes

Drug Profile

Epinephrine inhalation - Alkermes

Alternative Names: AIR Epinephrine

Latest Information Update: 27 Apr 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alkermes
  • Class Antiarrhythmics; Antihaemorrhagics; Antihypotensives; Bronchodilators; Catecholamines; Ethanolamines; Small molecules
  • Mechanism of Action Adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anaphylaxis

Most Recent Events

  • 31 May 2006 This compound is still in active development
  • 16 Mar 2004 Data presented at the 60th American Academy of Allergy, Asthma and Immunology (AAAAI-2004) conference have been added to the pharmacokinetics and pharmacodynamics section
  • 31 Aug 2003 Phase-I clinical trials in Anaphylaxis in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top